Back
Protagonist Therapeutics Stock Price Chart
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Sell
26
PTGX
Protagonist Therapeutics
Last Price:
41.14
Seasonality Move:
12.96%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing slight buying pressure.
Protagonist Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.49 | Sell |
| 20-day SMA: | 45.93 | Sell |
| 50-day SMA: | 45.52 | Sell |
| 200-day SMA: | 35.41 | Buy |
| 8-day EMA: | 43.6 | Sell |
| 20-day EMA: | 45.02 | Sell |
| 50-day EMA: | 44.54 | Sell |
| 200-day EMA: | 36.64 | Buy |
Protagonist Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.79 | Sell |
| Relative Strength Index (14 RSI): | 31.67 | Sell |
| Chaikin Money Flow: | 434003 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.11 - 48.03) | Sell |
| Bollinger Bands (100): | (37.47 - 46.31) | Sell |
Protagonist Therapeutics Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protagonist Therapeutics Stock
Is Protagonist Therapeutics Stock a Buy?
- Protagonist Therapeutics share price is 41.11 while PTGX 8-day simple moving average is 44.49, which is a Sell signal.
- The stock price of PTGX is 41.11 while Protagonist Therapeutics 20-day SMA is 45.93, which makes it a Sell.
- Protagonist Therapeutics 50-day simple moving average is 45.52 while PTGX share price is 41.11, making it a Sell technically.
- PTGX stock price is 41.11 and Protagonist Therapeutics 200-day simple moving average is 35.41, creating a Buy signal.
PTGX Technical Analysis vs Fundamental Analysis
Sell
26
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy or a Sell?
-
Protagonist Therapeutics stock is rated a Sell
The current Protagonist Therapeutics [PTGX] share price is $41.11. The Score for PTGX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Protagonist Therapeutics Stock Info
Market Cap:
2.45B
Price in USD:
41.11
Share Volume:
1.09M
Protagonist Therapeutics 52-Week Range
52-Week High:
48.89
52-Week Low:
15.58
Sell
26
Protagonist Therapeutics (PTGX)
is a Sell
Protagonist Therapeutics Share Price Forecast
-
What is the Protagonist Therapeutics stock price today?
The Protagonist Therapeutics stock price is 41.11 USD today. -
Will PTGX stock go up or go down?
Protagonist Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Protagonist Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protagonist Therapeutics is overvalued.
Is Protagonist Therapeutics Stock a Buy?
- Protagonist Therapeutics share price is 41.11 while PTGX 8-day exponential moving average is 43.60, which is a Sell signal.
- The stock price of PTGX is 41.11 while Protagonist Therapeutics 20-day EMA is 45.02, which makes it a Sell.
- Protagonist Therapeutics 50-day exponential moving average is 44.54 while PTGX share price is 41.11, making it a Sell technically.
- PTGX stock price is 41.11 and Protagonist Therapeutics 200-day simple moving average is 36.64, creating a Buy signal.
Fundamental Analysis of Protagonist Therapeutics
Is Protagonist Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $3.95 per share.
Technical Analysis of Protagonist Therapeutics
Should I short Protagonist Therapeutics stock?
- PTGX Moving Average Covergence Divergence (MACD) indicator is -0.79, suggesting Protagonist Therapeutics is a Sell
- Protagonist Therapeutics Relative Strength Index (RSI) is 31.67, which suggest Protagonist Therapeutics is oversold
- The Bollinger Bands (25) for Protagonist Therapeutics is (44.11 - 48.03), which suggest Protagonist Therapeutics is a Sell
- The Bollinger Bands (100) for Protagonist Therapeutics is (37.47 - 46.31), which suggest Protagonist Therapeutics is a Sell
* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.